Viewing generic prescription medicines in Australia - a consumers' perspective
MetadataShow full item record
This paper investigates consumer perception on generic medicines in Australia. Specifically, it examines how consumer concern and consumer knowledge about counterfeit medicines influence attitudes towards generic prescription medicine and willingness to pay more for branded prescription medicines. A research model is developed together with an agenda of nine hypotheses that contain consumer concern, consumer knowledge, attitude towards PGM, willingness to pay more for branded PM, consumer trust in internet shopping, and likelihood not to purchase PGM from legitimate drug store or Internet. Theory of Reasoned Action (TRA) is used to explain the results based on the proposed research model in this study. Mail surveys are implemented to reach mature age population as the segment of the sample. Other relationship within the model and a number of implications for businesses will be discussed, suggestions for future research are reviewed and the main contributions of the study will also be delineated.
Showing items related by title, author, creator and subject.
Liang, Johan; Phau, Ian (2010)This paper investigates consumer perception on prescription generic medicines (PGM) in Australia. Specifically, it examines how consumer concern and consumer knowledge about counterfeit medicines influence attitudes towards ...
Why does increasing public access to medicines differ between countries? Qualitative comparison of nine countriesGauld, N.; Bryant, L.; Emmerton, Lynne; Kelly, F.; Kurosawa, N.; Buetow, S. (2015)Objective: To identify factors associated with differences between developed countries in reclassifying (switching) medicines from prescription to non-prescription availability. Methods: Cross-national qualitative research ...
Widening Consumer Access to Medicines through Switching Medicines to Non-Prescription: A Six Country ComparisonGauld, N.; Kelly, F.; Kurosawa, N.; Bryant, L.; Emmerton, Lynne; Buetow, S. (2014)Background: Switching or reclassifying medicines with established safety profiles from prescription to non-prescription aims to increase timely consumer access to medicines, reduce under-treatment and enhance self-management. ...